Search for Clinical Trial Results

Sponsored By

Inflammatory Myofibroblastic Tumor - 2 Studies Found

Status Study
Recruiting Study Name: Phase I Study of LDK378 in Pediatric, Malignancies With a Genetic Alteration in Anaplastic Lymphoma Kinase (ALK)
Condition: Anaplastic Lymphoma Kinase (ALK)
Date: 2012-11-30
Interventions: Drug: LDK378 LDK378 is a capsule taken by mouth, contents can be mixed with food for pediatric patients
Recruiting Study Name: Phase 1/2 Study of X-396, an Oral ALK Inhibitor, in Patients With ALK-positive Non-Small Cell Lung Cancer
Condition:
  • Advanced Solid Tumors
  • Non-small Cell Lung Cancer

Date: 2012-06-15
Interventions: Drug: X-396 (ensartinib) Oral, ALK inhibitor